|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-1.24/-0.69
|
企業價值
175.93M
|
資產負債 |
每股賬面淨值
0.13
|
現金流量 |
現金流量率
--
|
損益表 |
收益
1.33M
|
每股收益
0.02
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
![](../images/dot.bmp)
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others. |